The Business Times
business-time-50

MediShield report: Panel of oncologists to look into high cost of cancer drugs

google-preferred-sourceAdd BT as a preferred source
Genevieve Cua

Genevieve Cua

Published Mon, Dec 21, 2020 · 09:50 PM
    Support and enhancements

    Singapore

    CHEMOTHERAPY claims have risen significantly for MediShield Life, and what is worrying is that the cost of cancer drugs in Singapore is also markedly higher than some places in the region.

    The MediShield Life Council will appoint a committee of oncologists to "review the coverage of cancer drugs, so that they can be covered in a more sustainable manner''.

    Insurance

    TRENDING NOW

    OCBC group CEO Tan Teck Long says the bank is looking to spend “north of S$1 billion” a year in the next few years to build infrastructure to support its AI initiatives.

    OCBC rolls out AI-native banking, to hire 600 relationship managers in wealth push

    Practices that once helped small businesses in Vietnam stay flexible and competitive in a low-margin economy are increasingly becoming formal business risks.

    Can Vietnam’s small-business backbone survive a compliance squeeze – all at once?

    Vincent Tan, founder of Berjaya Group, has reduced his holdings in multiple companies within the group.

    Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan

    The ruling upholds an earlier decision that rejected the bank’s application to strike out the action.

    High Court dismisses StanChart's appeal to strike out US$2.7 billion 1MDB-linked lawsuit

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More